PYGB and myocardial infarction: Initial clinical trials suggested a high sensitivity and good specificity of GPBB assays for the early detection of myocardial infarction compared with the other biomarkers, including first‐generation cardiac troponin T.36First generations of the troponin assays had unsatisfactory sensitivity, especially in the early phase of myocardial infarction.49